Literature DB >> 32392479

Co-pay cards in Canada: Improving choice or institutionalizing bribes?

Marc-André Gagnon1.   

Abstract

Mesh：

Year:  2019        PMID： 32392479      PMCID： PMC6861150          DOI： 10.1503/cmaj.191447

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  The cost of drug coupons.

Authors:  David Grande
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

2.  Patent watch: the patent cliff steepens.

Authors:  Charlotte Harrison
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

3.  Medication access through patient assistance programs.

Authors:  Danielle Chauncey; C Daniel Mullins; Bac V Tran; Diane McNally; Robert N McEwan
Journal:  Am J Health Syst Pharm       Date:  2006-07-01       Impact factor: 2.637

4.  The role and impact of cost-sharing mechanisms for prescription drug coverage.

Authors:  Marc-André Gagnon
Journal:  CMAJ       Date:  2017-05-15       Impact factor: 8.262

5.  [Three types of brand name loyalty strategies set up by drug manufacturers].

Authors:  Marie-Claude PréMont; Marc-André Gagnon
Journal:  Healthc Policy       Date:  2014-11

6.  Impact of brand drug discount cards on private insurer, government and patient expenditures.

Authors:  Michael R Law; Fiona K I Chan; Mark Harrison; Heather C Worthington
Journal:  CMAJ       Date:  2019-11-11       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.